News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Rachael Asselin, Brand Insights Contributor, Vice President, 1798, a Fingerpaint company

Advertisement

Articles by Rachael Asselin, Brand Insights Contributor, Vice President, 1798, a Fingerpaint company

Integrating Payers Into Your Digital Communication Plan

ByRachael Asselin, Brand Insights Contributor, Vice President, 1798, a Fingerpaint company
April 5th 2021

An evolving system requires a focus on digital channels

Advertisement

Latest Updated Articles

  • Integrating Payers Into Your Digital Communication Plan
    Integrating Payers Into Your Digital Communication Plan

    Published: April 5th 2021 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Will the Industry Continue to Research Psychedelics?

2

Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher

3

It’s Official: CMS Unveils Big Price Cuts for 15 High-Cost Medicare Drugs in Latest IRA Negotiation Round

4

FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers

5

How Will FDA's Priority Review Program Impact Domestic Manufacturing?

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us